FDA Inspection
Laveeza (nmi) Bhatti, M.D., Principle InvestigatorLaveeza (nmi) Bhatti, M.D., Principle Investigator – FDA Inspection, Dec 16, 2016
Record Details
This FDA Inspection record concerns Laveeza (nmi) Bhatti, M.D., Principle Investigator, with an inspection on December 16, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 16, 2016
- Product Type
- Drugs
- Person
- Yvonne T. Lacour (Issuing Officer)
View Company Profile
ID · ef21323c-ba42-4fc5-9cc3-4b63b1b8018a
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1000163
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.